Coastwise Capital Group LLC Has $442,000 Holdings in The Clorox Company (NYSE:CLX)

Coastwise Capital Group LLC reduced its holdings in The Clorox Company (NYSE:CLX) by 3.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,720 shares of the company’s stock after selling 89 shares during the quarter. Coastwise Capital Group LLC’s holdings in Clorox were worth $442,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. Thrivent Financial for Lutherans raised its holdings in Clorox by 8.7% during the 2nd quarter. Thrivent Financial for Lutherans now owns 8,855 shares of the company’s stock worth $1,208,000 after buying an additional 709 shares during the period. Public Sector Pension Investment Board raised its holdings in shares of Clorox by 75.6% during the second quarter. Public Sector Pension Investment Board now owns 4,775 shares of the company’s stock worth $652,000 after acquiring an additional 2,055 shares during the period. The Manufacturers Life Insurance Company lifted its position in Clorox by 2.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 75,023 shares of the company’s stock valued at $10,238,000 after acquiring an additional 1,494 shares in the last quarter. NewEdge Advisors LLC boosted its stake in Clorox by 3.5% in the 2nd quarter. NewEdge Advisors LLC now owns 16,747 shares of the company’s stock worth $2,285,000 after purchasing an additional 564 shares during the period. Finally, Quarry LP increased its holdings in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX opened at $160.28 on Friday. The firm has a market capitalization of $19.84 billion, a PE ratio of 55.85, a PEG ratio of 2.91 and a beta of 0.42. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The company’s 50-day moving average is $163.15 and its 200-day moving average is $158.01. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.49 earnings per share. Equities analysts forecast that The Clorox Company will post 6.86 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.04%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is 170.04%.

Analyst Ratings Changes

Several research firms have recently weighed in on CLX. DA Davidson upped their price objective on Clorox from $153.00 to $171.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Wells Fargo & Company upgraded shares of Clorox from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $155.00 to $157.00 in a report on Tuesday, January 7th. Evercore ISI reduced their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price target on shares of Clorox in a research report on Thursday. Finally, Barclays reduced their price objective on shares of Clorox from $139.00 to $130.00 and set an “underweight” rating for the company in a research note on Friday, January 17th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $156.07.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.